About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The main characteristic of our group is its multidisciplinary nature, as it is comprised of neuroradiologists, technologists, and a physicist, engineer, and biochemist.
The main objectives of our projects are to gain knowledge about the pathophysiologic mechanisms implicated in several neurological diseases and to evaluate new biomarkers and therapies through the use of qualitative and quantitative magnetic resonance (MR) and computed tomography (CT) techniques, and by applying artificial intelligence tools to create prognostic models. Our focus is on the study of diseases such as multiple sclerosis, epilepsy, neuro-oncology, and stroke.
In addition, because of the experience we have acquired along the years in performing MR studies, we act as a platform for designing MR-based projects, processing images, and conducting quantitative data analysis.
PMID: 35332015 Journal: AMERICAN JOURNAL OF NEURORADIOLOGY Year: 2022 Reference: AJNR Am J Neuroradiol. 2022 Apr;43(4):534-539. doi: 10.3174/ajnr.A7474. Epub 2022 Mar 24. Impact factor: 3.825 Publication type: Paper in international publication Authors: Caruana, G, Auger, C, Pessini, L M, Calderon, W, de Barros, A, Salerno, A, Sastre-Garriga, J, Montalban, X, Rovira, A et al. DOI: 10.3174/ajnr.A7474
PMID: 35202997 Journal: NeuroImage-Clinical Year: 2022 Reference: Neuroimage Clin. 2022;34:102967. doi: 10.1016/j.nicl.2022.102967. Epub 2022 Feb 16. Impact factor: 4.881 Publication type: Paper in international publication Authors: Boaventura, Mateus, Sastre-Garriga, Jaume, Garcia-Vidal, Aran, Vidal-Jordana, Angela, Quartana, Davide, Carvajal, Rene, Auger, Cristina, Alberich, Manel, Tintore, Mar, Rovira, Alex et al. DOI: 10.1016/j.nicl.2022.102967
PMID: 35048162 Journal: NEURORADIOLOGY Year: 2022 Reference: Neuroradiology. 2022 Jul;64(7):1383-1390. doi: 10.1007/s00234-021-02885-7. Epub 2022 Jan 20. Impact factor: 2.804 Publication type: Paper in international publication Authors: Pareto, Deborah, Garcia-Vidal, Aran, Groppa, Sergiu, Gonzalez-Escamilla, Gabriel, Rocca, Mara, Filippi, Massimo, Enzinger, Christian, Khalil, Michael, Llufriu, Sara, Sastre-Garriga, Jaume et al. DOI: 10.1007/s00234-021-02885-7
The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.
Els doctors Xavier Montalban, Àlex Rovira i Mar Tintoré han estat reconeguts en la categoria de Neurociències i Comportament, i el doctor Jordi Rello en la categoria Interdisciplinària.
The program, promoted by Biocat in collaboration with CIMIT (Boston), is aimed at entrepreneurs in the process of bringing their technology to market in the next few years.
Magnetic Resonance image analysis
